Tokyo Tape
Sign in

Wakamoto Pharmaceutical

4512.TPharmaceutical
Major holders (5%+) · 2
HolderStakeChangeFiled
Asset Value Investors Limited11.64%+1.04pp2026-08-27
ROHTO PHARMACEUTICAL CO., LTD.11.40%—2025-02-13

Each holder's own ratio from its most recent large-shareholding report.

Ownership history · 6
FiledHolderRatioChangePurpose
2026-08-27Asset Value Investors Limited2026-08-2711.64%+1.04ppMaterial proposals to management (activist); Pure investment
2025-02-27AmendedAsset Value Investors Limited2025-02-27 · amended10.60%+1.02ppMaterial proposals to management (activist); Pure investment
2025-02-27AmendedAsset Value Investors Limited2025-02-27 · amended9.58%+1.04ppMaterial proposals to management (activist); Pure investment
2025-02-27AmendedAsset Value Investors Limited2025-02-27 · amended8.54%+1.09ppMaterial proposals to management (activist); Pure investment
2025-02-27AmendedAsset Value Investors Limited2025-02-27 · amended7.45%newMaterial proposals to management (activist); Pure investment
2025-02-13ROHTO PHARMACEUTICAL CO., LTD.2025-02-1311.40%new—

Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.